Authors:
VANDEVRIE W
MARQUET RL
STOTER G
DEBRUIJN EA
EGGERMONT AMM
Citation: W. Vandevrie et al., IN-VIVO MODEL SYSTEMS IN P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE, Critical reviews in clinical laboratory sciences, 35(1), 1998, pp. 1-57
Authors:
VANIJKEN MGA
DEBRUIJN EA
WIGGERS T
VANEIJCK CHJ
VANDERSIJP JRM
TENHAGEN TLM
EGGERMONT AMM
Citation: Mga. Vanijken et al., HYPOXIC PERFUSION OF PELVIS, ABDOMEN AND LIVER WITH TNF-ALPHA MELPHALAN AND MITOMYCIN-C USING NEW BALLOON CATHETER TECHNIQUES - PHARMACOKINETICS IN PIGS, European journal of cancer, 34, 1998, pp. 180-180
Authors:
HIGHLEY MS
SCHRIJVERS D
ARDIET C
VANOOSTEROM AT
DEBRUIJN EA
Citation: Ms. Highley et al., PHARMACOKINETICS OF THE MITOMYCIN KW-2149 - GENERATION OF THE ACTIVE METABOLITE M-18, Annals of oncology, 9, 1998, pp. 480-480
Authors:
PRONK LC
SCHRIJVERS D
SCHELLENS JHM
DEBRUIJN EA
PLANTING AST
LOCCITONELLI D
GROULT V
VERWEIJ J
VANOOSTEROM AT
Citation: Lc. Pronk et al., DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS - RESULTS OF A PHASE-I STUDY, Seminars in oncology, 25(1), 1998, pp. 23-28
Authors:
PRONK LC
SCHRIJVERS D
SCHELLENS JHM
DEBRUIJN EA
PLANTING AST
LOCCITONELLI D
GROULT V
VERWEIJ J
VANOOSTEROM AT
Citation: Lc. Pronk et al., PHASE-I STUDY ON DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS, British Journal of Cancer, 77(1), 1998, pp. 153-158
Authors:
DEBOER D
TAN LP
GORTER P
VANDEWAL RMA
KETTENESVANDENBOSCH JJ
DEBRUIJN EA
MAES RAA
Citation: D. Deboer et al., GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ASSAY FOR PROFILING THE ENANTIOMERS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS CHIRAL METABOLITES USING POSITIVE CHEMICAL-IONIZATION ION-TRAP MASS-SPECTROMETRY, Journal of mass spectrometry., 32(11), 1997, pp. 1236-1246
Authors:
DEBOECK G
VANCAUWENBERGHE K
EGGERMONT AMM
VANOOSTEROM AT
DEBRUIJN EA
Citation: G. Deboeck et al., CE DETERMINATION OF THE CYTOKINE TNF-ALPHA IN PERFUSION SAMPLES FROM CANCER-PATIENTS, HRC. Journal of high resolution chromatography, 20(5), 1997, pp. 295-297
Authors:
DEBOECK G
VANCAUWENBERGHE K
EGGERMONT AMM
VANOOSTEROM AT
DEBRUIJN EA
Citation: G. Deboeck et al., DETERMINATION OF MELPHALAN AND HYDROLYSIS PRODUCTS IN BODY-FLUIDS BY GC-MS, HRC. Journal of high resolution chromatography, 20(12), 1997, pp. 697-700
Authors:
HIGHLEY MS
SCHRIJVERS D
VANOOSTEROM AT
HARPER PG
MOMERENCY G
VANCAUWENBERGHE K
MAES RAA
DEBRUIJN EA
EDELSTEIN MB
Citation: Ms. Highley et al., ACTIVATED OXAZAPHOSPHORINES ARE TRANSPORTED PREDOMINANTLY BY ERYTHROCYTES, Annals of oncology, 8(11), 1997, pp. 1139-1144
Authors:
GHEUENS EEO
VANDERHEYDEN SAM
ELST HE
VANOOSTEROM AT
DEBRUIJN EA
Citation: Eeo. Gheuens et al., COMPARISON OF DAUNORUBICIN AND FLUO-3 FOR DETECTION OF MULTIDRUG-RESISTANCE IN HUMAN TUMOR-CELLS, Cancer detection and prevention, 21(1), 1997, pp. 78-82
Authors:
EGELMEERS A
DIRIX LY
LYCZEK J
DEBRUIJN EA
VANOOSTEROM AT
SCALLIET P
Citation: A. Egelmeers et al., THE INFLUENCE OF HYPOXIA ON THE CYTOTOXICITY OF CONCOMITANT KW-2149 AND IONIZING IRRADIATION IN CHINESE-HAMSTER FIBROBLASTS, Anti-cancer drugs, 7(5), 1996, pp. 586-590
Citation: Ms. Highley et Ea. Debruijn, ERYTHROCYTES AND THE TRANSPORT OF DRUGS AND ENDOGENOUS COMPOUNDS, Pharmaceutical research, 13(2), 1996, pp. 186-195
Authors:
VERMEULEN PB
ROLAND L
MERTENS V
VANMARCK E
DEBRUIJN EA
VANOOSTEROM AT
DIRIX LY
Citation: Pb. Vermeulen et al., CORRELATION OF INTRATUMORAL MICROVESSEL DENSITY AND P53 PROTEIN OVEREXPRESSION IN HUMAN COLORECTAL ADENOCARCINOMA, Microvascular research, 51(2), 1996, pp. 164-174
Authors:
MOMERENCY G
VANCAUWENBERGHE K
HIGHLEY MS
HARPER PG
VANOOSTEROM AT
DEBRUIJN EA
Citation: G. Momerency et al., PARTITIONING OF IFOSFAMIDE AND ITS METABOLITES BETWEEN RED-BLOOD-CELLS AND PLASMA, Journal of pharmaceutical sciences, 85(3), 1996, pp. 262-265
Authors:
HIGHLEY MS
HARPER PG
SLEE PHTJ
DEBRUIJN EA
Citation: Ms. Highley et al., PREFERENTIAL LOCATION OF CIRCULATING ACTIVATED CYCLOPHOSPHAMIDE WITHIN THE ERYTHROCYTE, International journal of cancer, 65(5), 1996, pp. 711-712
Authors:
DEPOOTER CM
VANOOSTEROM AT
SCALLIET PG
MAES RA
DEBRUIJN EA
Citation: Cm. Depooter et al., CORRELATION OF THE RESPONSE TO CISPLATIN OF HUMAN OVARIAN-CANCER CELL-LINES, ORIGINATING FROM ONE TUMOR BUT WITH DIFFERENT SENSITIVITY, WITH THE RECOVERY OF DNA-ADDUCTS, Biochemical pharmacology, 51(5), 1996, pp. 629-634
Authors:
VERMEULEN PB
ROLAND L
MERTENS V
VANMARCK E
DEBRUIJN EA
OOSTEROM AT
DIRIX LY
Citation: Pb. Vermeulen et al., MICROVESSEL DENSITY P53 OVEREXPRESSION IN COLORECTAL ADENOCARCINOMA, European journal of cancer, 31A, 1995, pp. 722-722
Authors:
VERMEULEN PB
VERHOEVEN D
HUBENS G
VANMARCK E
GOOVAERTS G
HUYGHE M
DEBRUIJN EA
VANOOSTEROM AT
DIRIX LY
Citation: Pb. Vermeulen et al., MICROVESSEL DENSITY, ENDOTHELIAL-CELL PROLIFERATION AND TUMOR-CELL PROLIFERATION IN HUMAN COLORECTAL ADENOCARCINOMAS, Annals of oncology, 6(1), 1995, pp. 59-64
Authors:
BARBERIHEYOB M
WEBER B
MERLIN JL
DITTRICH C
DEBRUIJN EA
LUPORSI E
GUILLEMIN F
Citation: M. Barberiheyob et al., EVALUATION OF PLASMA 5-FLUOROURACIL NUCLEOSIDE LEVELS IN PATIENTS WITH METASTATIC BREAST-CANCER - RELATIONSHIPS WITH TOXICITIES, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 110-116
Authors:
SORBER M
DEBRUIJN EA
KOCKX M
BULTINCK J
VANOOSTEROM AT
DENIS L
Citation: M. Sorber et al., EFFECTS AND SYSTEMIC UPTAKE OF THE NEW MITOMYCIN-C ANALOG KW-2149 IN BEAGLE DOGS AFTER INTRAVESICAL ADMINISTRATION, Urological research, 23(3), 1995, pp. 157-161
Authors:
HIGHLEY MS
MOMERENCY G
VANCAUWENBERGHE K
VANOOSTEROM AT
DEBRUIJN EA
MAES RAA
BLAKE P
MANSI J
HARPER PG
Citation: Ms. Highley et al., FORMATION OF CHLOROETHYLAMINE AND 1,3-OXAZOLIDINE-2-ONE FOLLOWING IFOSFAMIDE ADMINISTRATION IN HUMANS, Drug metabolism and disposition, 23(3), 1995, pp. 433-437